TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive DCPC Advisors OK Expansion Of Science Enrichment Program, Other Concepts November 1, 1991